RGNX

RGNX

USD

REGENXBIO Inc. Common Stock

$11.560+0.140 (1.226%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$11.420

Máximo

$11.955

Mínimo

$11.375

Volumen

0.20M

Fundamentos de la Empresa

Capitalización de Mercado

583.9M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.60M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $5.035Actual $11.560Máximo $13.925

Noticias Relacionadas

PR Newswire

REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program

REGENXBIO Inc. (Nasdaq: RGNX) today announced the completion of enrollment in the AFFINITY DUCHENNE® pivotal trial of RGX-202, an investigational...

Ver más
REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
PR Newswire

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial...

Ver más
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
PR Newswire

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: Chardan's 9th Annual Genetic Medicines...

Ver más
REGENXBIO to Participate in Upcoming Investor Conferences

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.